FDA’s revised quality metrics plan praised for offering greater flexibility
Regulatory NewsJoanne S. Eglovitch
APIsNorth AmericaPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory NewsJoanne S. EglovitchAPIsNorth AmericaPharmaceuticalsProduct LifecycleQuality Assurance and Control